Iovance Biotherapeutics (IOVA) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Iovance Biotherapeutics (IOVA) over the last 14 years, with Q3 2025 value amounting to $385.5 million.
- Iovance Biotherapeutics' Shares Outstanding rose 2653.84% to $385.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $385.5 million, marking a year-over-year increase of 2653.84%. This contributed to the annual value of $305.3 million for FY2024, which is 1917.6% up from last year.
- According to the latest figures from Q3 2025, Iovance Biotherapeutics' Shares Outstanding is $385.5 million, which was up 2653.84% from $341.9 million recorded in Q2 2025.
- Over the past 5 years, Iovance Biotherapeutics' Shares Outstanding peaked at $385.5 million during Q3 2025, and registered a low of $224.4 million during Q1 2023.
- In the last 3 years, Iovance Biotherapeutics' Shares Outstanding had a median value of $297.3 million in 2024 and averaged $291.8 million.
- In the last 5 years, Iovance Biotherapeutics' Shares Outstanding surged by 3231.92% in 2024 and then surged by 1500.59% in 2025.
- Iovance Biotherapeutics' Shares Outstanding (Quarter) stood at $256.1 million in 2023, then grew by 19.18% to $305.3 million in 2024, then grew by 26.28% to $385.5 million in 2025.
- Its last three reported values are $385.5 million in Q3 2025, $341.9 million for Q2 2025, and $333.9 million during Q1 2025.